Barely Significant
← all phrases

“a strong trend”

5,726 sentences · 5,726 papers · 7,352 search hits before verification · confirmed specimen

Sighted at

p=0.077

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

VKA treatment reduces overall mortality by 26 % relative to placebo [ 14 ], and it is notable that all NOACs tested in phase III trials also demonstrated a strong trend towards reduced all-cause mortality in the ITT population compared with warfarin; this was statistically significant only for apixaban versus warfarin (HR, 0.89; p = 0.047) [ 23 ] and was close to statistical significance for the 150 mg bid dose of dabigatran (relative risk, 0.88; p = 0.051) [ 21 ].
Regarding accuracy, the DSC similarity results show a strong trend towards the MVEE ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$0.80\pm 0.03$$\end{document} 0.80 ± 0.
However, even if our results about efficacy are significant, we acknowledge that our study displays limitations, including the small number of patients in the compared groups with 12 patients in the “matched therapy group”, and 25 in the “non-matched therapy group”, and the imbalance of characteristics between these groups with a strong trend for more patients with PC in the first one (83%) than in the second one (44%).